CE vs CERS · rev $10.28B vs rev $201.3M
Celanese Corporation (CE) versus Cerus Corporation (CERS) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Cerus Corporation (CERS) is a medical devices company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
CE currently screens at market cap $5.92B. CERS currently screens at market cap $294.4M.
Not investment advice. Open the CE and CERS stock pages for the full models.
Not investment advice.